NEW YORK, Sept 7 - DNA Sciences of Mountain View, Calif., announced on Thursday the opening of its genetic analysis facility, which seeks to find new links between genetics and disease.
The facility, which was opened in collaboration with Amersham Pharmacia Biotech, will use more than 40 of APB’s MegaBACE 1000 DNA Analysis Systems that will be configured to genotype large quantities of DNA.
The companies will also work together to improve genotyping techniques, software, and automation methods on the MegaBACE platform, DNA Sciences said in a statement.
“Our MegaBACE facility will be a critical asset to our researchers who are analyzing the DNA of thousands of volunteers, including those from the recently launched DNA Sciences Gene Trust Project,” Ray White, chief scientific officer of DNA Sciences, said in a statement.
DNA Sciences operates the Gene Trust Project, a large-scale research initiative that relies on volunteers to donate their DNA for analysis. The company believes it will be able to use the donated DNA to discover links between genetics and disease.
Amersham Pharmacia Biotech of Uppsala , Sweden is the life sciences division of Nycomed Amersham (NYSE: NYE).